“…A case report published in 1954 described a patient anticoagulated with ethyl biscoumacetate who experienced increased prothrombin activity following cortisone therapy. 4 This patient required an increase in the oral anticoagulation dose to reestablish a therapeutic concentration. An early study evaluated the effects of a single oral dose of prednisone 10 mg in 24 patients receiving dicumarol.…”
Use of oral corticosteroids in patients on long-term warfarin therapy may result in a clinically significant interaction, which requires close INR monitoring and possible warfarin dose reduction.
“…A case report published in 1954 described a patient anticoagulated with ethyl biscoumacetate who experienced increased prothrombin activity following cortisone therapy. 4 This patient required an increase in the oral anticoagulation dose to reestablish a therapeutic concentration. An early study evaluated the effects of a single oral dose of prednisone 10 mg in 24 patients receiving dicumarol.…”
Use of oral corticosteroids in patients on long-term warfarin therapy may result in a clinically significant interaction, which requires close INR monitoring and possible warfarin dose reduction.
“…Deep venous thrombosis as a complication of steroid therapy was first pointed out by Cosgriff in 1950. Since then there have been several reports of association of deep vein thrombosis and Corticosteroid therapy 5,6 . Mukjerjee et al in 1970 described several cases of deep vein thrombosis in children receiving intermittent Corticosteroids in high dosage for nephrotic syndrome.…”
Section: Discussionmentioning
confidence: 99%
“…Spontaneous forms are associated with either underlying disease such as malignancy of the pancreas or other organs. Corticosteroid therapy has been implicated as a precipitating factor in deep vein thrombosis by various workers 3,4,5,6 . However, in these cases where association of DVT and Steroid therapy has been described thrombosis involved renal veins or veins of lower rather than upper extremities.…”
“…Rawls (1951), in a large series of patients treated with ordinary corticotrophin or cortisone, found the incidence to be 3%. Ragan (1952) and Chatterjea and Salomon (1954) also have drawn attention to the development of thrombo-embolic phenomena. During corticotrophin or cortisone therapy, Cosgriff et al (1950) and Cosgriff (1951) observed an increased coagulability of the blood, which persisted for several weeks after withdrawal.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.